BlackRock Amends Alector Stake, Maintains Passive Position

Ticker: ALEC · Form: SC 13G/A · Filed: 2024-01-24T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

TL;DR

**BlackRock updated its Alector stake, still a big passive holder.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, disclosing its ownership in Alector, Inc. as of December 31, 2023. This filing, Amendment No. 3, indicates BlackRock's continued significant, but passive, stake in the biotechnology company. This matters to investors because BlackRock is a major institutional investor, and their holdings can signal confidence or a shift in sentiment towards Alector, Inc.'s stock.

Why It Matters

BlackRock's updated filing provides transparency into its substantial, yet passive, investment in Alector, Inc., which can influence market perception and investor confidence in the stock.

Risk Assessment

Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate risk or significant change in strategy.

Analyst Insight

An investor should note that BlackRock's continued passive stake suggests no immediate change in their investment thesis for Alector, Inc. and should monitor future filings for any shifts in ownership percentage or filing type (e.g., a 13D), which could signal a more active role.

Key Players & Entities

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 3, as stated in the filing.

Who is the reporting entity in this filing?

The reporting entity is BlackRock Inc., as indicated in the 'FILED BY' section and the 'Names of reporting person' on the cover page.

What is the subject company whose shares are being reported?

The subject company is Alector, Inc., as stated under 'Name of Issuer' and in the 'SUBJECT COMPANY' data section.

What is the date of the event that required this filing?

The date of the event which required the filing of this statement is December 31, 2023, as specified on the cover page.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' next to '[X] Rule 13d-1(b)' on the cover page.

From the Filing

0001086364-24-002352.txt : 20240124 0001086364-24-002352.hdr.sgml : 20240124 20240124142718 ACCESSION NUMBER: 0001086364-24-002352 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822933343 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90858 FILM NUMBER: 24555919 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us0144421072_012424.txt us0144421072_012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) ALECTOR INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 014442107 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 014442107 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 7599574 (6) Shared voting power 0 (7) Sole dispositive power 8068553 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 8068553 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 9.6% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- ALECTOR INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- B

View on Read The Filing